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ABSTRACT
Objective: To determine whether there is evidence
that mass-media campaigns can be effective in
reducing illicit drug consumption and the intent to
consume.
Design: Systematic review of randomised and non-
randomised studies.
Methods: We searched four electronic databases
(MEDLINE, EMBASE, ProQuest Dissertations & Theses
A&I and CENTRAL) and further explored seven
additional resources to obtain both published and
unpublished materials. We appraised the quality of
included studies using standardised tools. We carried
out meta-analyses of randomised controlled trials and
a pooled analysis of interrupted time-series and
controlled before-and-after studies.
Results: We identified 19 studies comprising 184 811
participants. Pooled analyses and narrative synthesis
provided mixed evidence of effectiveness. Eight
interventions evaluated with randomised controlled
trials leaned towards no evidence of an effect, both on
drug use (standardised mean difference (SMD) −0.02;
95% CI −0.15 to 0.12) and the intention to use drugs
(SMD −0.07; 95% CI −0.19 to 0.04). Four campaigns
provided some evidence of beneficial effects in
preventing drug use and two interventions provided
evidence of iatrogenic effects.
Conclusions: Studies were considerably
heterogeneous in type of mass-media intervention,
outcome measures, underlying theory, comparison
groups and design. Such factors can contribute to
explaining the observed variability in results. Owing to
the risk of adverse effects, caution is needed in
disseminating mass-media campaigns tackling drug
use. Large studies conducted with appropriate
methodology are warranted to consolidate the evidence
base.
INTRODUCTION
Mass-media campaigns are a powerful means
for disseminating health promotion mes-
sages. A wide and diverse audience can be
reached through television commercials, the
Internet, mobile phones, newspapers and
roadside advertising hoardings. In the field
of drug addiction and dependence, adver-
tisements may contribute to shaping patterns
of drug use and the intention to use drugs,
as well as modifying mediators such as aware-
ness, knowledge and attitudes about drugs.
However, ethical and economic considera-
tions are often raised. Mass-media campaigns
—unlike other health interventions—are
imposed on populations that have not con-
sented to their implementation.1 This is a
considerable ethical issue in modern, person-
centred public health, where taking decisions
shared with the public is essential for pro-
moting behaviour change. Second, mass-
media campaigns can be very expensive,
especially when implemented at the national
or state level. Large-scale purchasing of
Strengths and limitations of this study
▪ This systematic review is based on an expanded
evidence base of both published and unpub-
lished findings and aims to determine whether
mass-media campaigns can be effective in pre-
venting the use of or intention to use illicit
drugs.
▪ Pooled analyses of eight mass-media interven-
tions provide no evidence of an effect on drug
use or intention to use illicit drugs. Four inter-
ventions provide evidence of beneficial effects.
Two interventions provide evidence of iatrogenic
effects.
▪ Owing to the paucity and inconsistency of avail-
able evidence, we cannot draw general conclu-
sions as to whether mass-media interventions
are effective in preventing the use of or intention
to use illicit drugs.
▪ This review provides an insight into research
gaps around the impact of mass-media drug pre-
vention interventions and can serve to highlight
that new campaigns should be implemented in
the framework of rigorous evaluation studies, in
order to avoid dissemination of interventions that
are ineffective or have unintended effects.
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public service announcement time during popular
shows and broad dissemination via printed media are
often accessible only to governmental institutions. For
example, the first and second versions of the US Office
of National Drug Control Policy’s National Youth
Anti-Drug Media Campaign cost 2.7 billion dollars over
more than 10 years.2 Although such campaigns under-
went careful evaluation, most mass-media interventions
are not developed in compliance with the classical circle
of public health, which consists in designing interven-
tions based on evidence and in evaluating their impact.
A systematic review of the studies assessing media cam-
paigns aiming to prevent use of illicit drugs can inform
future strategies and help design effective campaigns.
The objective of this review is to assess the effectiveness
of mass-media campaigns in preventing or reducing
drug use or the intention to use illicit drugs among
young people.
METHODS
We conducted this systematic review in accordance with
the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA)3 statement and with the proce-
dures specified in a previously published protocol.4 As
described in detail previously,4 we systematically searched
four electronic databases: MEDLINE (1966 to 29 January
2013), EMBASE (1974 to 30 January 2013), ProQuest
Dissertations and Theses A&I (1861 to 3 February 2013)
and CENTRAL (2013, Issue 1). Search strategies are avail-
able as supplementary files (see online supplementary
appendix 1). We further explored seven additional
resources to obtain both published and unpublished
materials: four websites of registered studies (ie, http://
www.controlled-trials.com, http://apps.who.int/trialsearch/,
http://clinicaltrials.gov/, https://eudract.emea.europa.
eu/), references embedded in book chapters, references
included in the annual national reports written by
EMCDDA national focal points and any publications
recommended by prominent researchers in the field. We
did not set any constraints, such as language or time, to
our search.
Selection criteria
As described in detail previously,4 we considered studies
involving participants under the age of 26 and evaluat-
ing mass-media campaigns explicitly aimed at influen-
cing the use or intention to use illicit drugs.5 The
following were deemed acceptable comparison groups:
(1) no intervention; (2) community-based or school-
based drug prevention programmes; (3) lower exposure
to intervention; (4) time before exposure to interven-
tion. We included randomised controlled trials (RCTs),
cohort studies, interrupted time-series (ITS) studies and
controlled before and after (CBA) studies providing evi-
dence on drug use or intention not to use, to reduce
use or to stop use of illicit drugs.
Two authors independently inspected search hits by
reading titles and abstracts and assessed studies for inclu-
sion. Any disagreement was solved by consensus.
Multiple publications pertaining to the same study were
collated as one single study.
Quality Appraisal
Four authors independently performed quality assess-
ments, and any disagreement was solved by consensus.
We contacted study authors whenever information was
missing or unclear.
We used standardised assessment tools for each study
design—details are available as supplementary materials
(see online supplementary appendix 2). For RCTs, we
used the Cochrane Collaboration Risk of Bias assessment
tool.6 For cohort studies, we followed the Scottish
Intercollegiate Guidelines Network (SIGN) Quality
Criteria.7 For ITS and CBA studies, we used the tool
recommended by the Cochrane Effective Practice and
Organisation of Care Group.8
Statistical analysis
As for RCTs, we performed a random effects
meta-analysis to estimate the pooled effect of mass-
media interventions on drug use while accounting for
between-study heterogeneity, as described in detail previ-
ously.4 We carried out a fixed effects meta-analysis to esti-
mate the pooled intervention effect on intention to use
drugs. We tested between-study heterogeneity using the
χ2 test and the I2 statistic. A p value lower than 0.10 in
the χ2 test and an I2 statistic higher than 50% suggested
evidence of heterogeneity. Since most studies assessed
their outcome variables with different scales, we used
standardised mean difference (SMD) as the summary
measure of choice. SMDs were used for both drug use
and intention to use drugs and were calculated by divid-
ing the difference in mean outcome between groups by
the SD of outcome between participants.6 SMDs and
their SEs were then pooled in a meta-analysis performed
with RevMan.9 For two clustered RCTs,10 11 we inflated
SEs to account for within-cluster correlations.6
We pooled the effect estimates of the Meth Project
studies using mixed effects logistic regression.12–16 An
ITS design was applied for estimating the differences in
prevalence of methamphetamine use before and after
the Meth Project intervention, adjusting for any under-
lying temporal trend. We fitted the following model:
logit(useij)=β0+u0j+β1timei+β2agei+β3intervi+β4age×intervi,
in which use was prevalence of methamphetamine use,
time was a continuous variable, age and intervention
were two-level categorical variables, u0j was a random
intercept and we allowed log odds of methamphetamine
use to vary randomly by each jth state.17 The relatively
few data points did not allow exploration of more
complex models, for example, the temporal trend could
not be assumed to vary randomly across states.
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RESULTS
Out of 18 343 titles and abstracts, we selected 24 papers
corresponding to 19 individual studies (figure 1).
Study Characteristics
Overall, 184 811 participants were included, with most
studies comprising participants who were aged between
10 and 19 years (table 1). Although most studies
included both boys and girls, two studies focused on
girls.18 19 One study considered Asian-Americans as the
only ethnic group eligible for inclusion,18 while the
other study did not focus on any specific ethnic groups.
Seventeen studies were conducted in the USA, one in
the USA and Canada,19 and one in Australia.11
Eleven studies (58%) evaluated multicomponent inter-
ventions, 3 regarding radio/television and printed adver-
tising,10 20 21 and 8 regarding radio and television
commercials, printed advertisements and Internet adver-
tising.2 12–16 22 23 Eight studies evaluated standalone inter-
ventions, four consisting in radio and television
commercials,24–27 and four in Internet-based interven-
tions.11 18 19 28 The included studies in this review were
grounded in a wide range of underlying theories (table 1).
Comparison groups varied considerably across studies.
For thirteen studies (68%), the comparison group con-
sisted in no exposure to any intervention. Four studies
compared high exposure versus low exposure to the
same mass media intervention.2 21–23 For one study, the
comparison group consisted in the standard drug educa-
tion curriculum.11 One study had four study arms con-
sisting either in another intervention or no
intervention.26
Eight studies were conducted in an experimental
setting by explicitly inviting participants and these studies
were randomised controlled trials (RCTs).10 11 18 19 25–28
Ten studies were conducted in a field setting without
explicitly inviting participants, as would usually happen
with most mass-media campaigns. Of them, 2 were cohort
studies,22 23 6 were ITS2 12 14–16 24 and 2 were CBA
studies.13 20 One study had a double design as it was con-
ducted in an experimental setting with an RCT design,
and in a field setting with a cohort design.21 When speci-
fied, follow-up varied from 6 months19 28 to 4.7 years.22
Study quality
On the whole, the quality of the RCTs is acceptable
(table 2). As described in detail previously,4 the strongest
domain appears to be the risk of attrition bias and the
weakest domain the risk of selection bias (unclear
description of the randomisation procedure). In one
paper, findings of secondary outcomes were reported
only as a predictor of the primary outcome, and the
paper concerned was deemed at high risk for reporting
bias.19
Figure 1 PRISMA flow diagram.
Adapted from a previous
publication.4
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Table 1 Characteristics of included studies
Study Underpinning theory
Design
(goal) Intervention Comparison Primary outcome Secondary outcome(s)
Analysis
sample
Follow-up
(total time)
(months)
Polansky et al
199925
Decision theory RCT (E) PSA Other – Intention to use; attitudes;
knowledge and disposition to
select socially appropriate
responses
312 NA (NS)
Miller et al
200020
Self-regulation theory CBA (F) PSA; printed No
intervention
Use of drugs (incl.
cannabis and cocaine)
Risk perception; problems related
to drug use
1024 12 (18)
Palmgreen
et al 200124
Influence of sensation-seeking
on drug use
ITS (F) PSA No
intervention
Past 30-day use of
marijuana
– 6371 NA (32)
Yzer et al
200326
Theories of behavioural
change: persuasion effects
RCT (E) PSA No
intervention;
other
– Intention to use marijuana;
attitude; perceptions about
marijuana
418 NA (NS)
Slater et al
200610
Social-ecological framework
(norms and expectations
influence drug use)
RCT (E) PSA; printed No
intervention
Lifetime and past 30-day
use of marijuana
– 4216 24 (42)
Zhao et al
200627
Normative beliefs RCT (E) PSA No
intervention
– Intention to use; beliefs towards
marijuana; social norms
435 NS (NS)
Hornik 200622 Unclear Cohort (F) PSA; printed;
internet
Lower
exposure
Lifetime, past year, and
past 30-day use of
marijuana
Intention to use; attitudes and
self-efficacy; perceptions and
social norms
8117 56 (58)
Scheier and
Grenard
201023
Social marketing Cohort (F) PSA; printed;
internet
Lower
exposure
Past 12-month cannabis
intoxications
– 2515 NA (48)
Schwinn et al
201019
Social learning theory RCT (E) Internet No
intervention
Past 30-day substance
use
– 236 6 (NS)
Lee et al
201028
Readiness to change RCT (E) Internet No
intervention
Past 90-day use of
marijuana
Intention to change marijuana use;
consequences
341 6 (NS)
Fang et al
201018
Family-oriented RCT (E) Internet No
intervention
Past 30-day use of
marijuana
Intention to use marijuana 216 6.25 (16)
Newton et al
201011
Social influence approach RCT (E) Internet Other Use of cannabis Cannabis knowledge; attitudes;
related harms
724 12 (21)
Meth Project
studies12–16
Perception of risk and
perception of social
disapproval are correlated with
drug consumption
4 ITS and
1 CBA (F)
PSA; printed;
internet
No
intervention
Past 30-day use of
methamphetamine
Attitudes on methamphetamine
and other drugs; perceptions;
information sources and
advertising awareness;
26 405 NA
(Colorado 26;
Georgia 18;
Hawaii 25;
Idaho 40;
Wyoming 34)
Slater et al
201121
Autonomy and aspiration
perceptions as mediators of
marijuana use
RCT (E);
Cohort (F)
PSA; printed Lower
exposure
Lifetime, past 90-day
and past 30-day use of
marijuana
Autonomy and aspiration
inconsistent with marijuana use
3236 24 (42)
Carpenter and
Pechmann
20112
Unclear; evaluated many
heterogeneous mass-media
campaigns
ITS (F) PSA; printed;
internet
Lower
exposure
Past 30-day and lifetime
use of marijuana
– 130 245 NA (36)
CBA, controlled before and after; Cohort, prospective cohort; E, experimental/efficacy setting; F, field/effectiveness setting; ITS, interrupted time-series; Lower exposure, lower exposure to same
intervention; NA, not applicable; NS, not specified; Other, other intervention or different combination of same intervention; PSA, public service announcement (eg, television/radio); RCT,
randomised controlled trial.
4
Allara
E,etal.BM
J
Open
2015;5:e007449.doi:10.1136/bm
jopen-2014-007449
O
p
e
n
A
c
c
e
s
s
group.bmj.com
 o
n
 Septem
ber 6, 2015 - Published by 
http://bmjopen.bmj.com/
D
ow
nloaded from
 
Table 2 Risk of bias of included studies
Design Study
Random
sequence
generation
Allocation
concealment
Blinding of
outcome
assessment Attrition
Selective
reporting
Comparability
of groups
Acceptance
among
recruited
Attrition
by
exposure
status
Strategies
alternative
to blinding
Discussion
of potential
confounders
Statistical
accuracy
Overall
risk of
bias
(cohort)
Sufficient
data points
for
inference
RCT Polansky et al199925
Yzer et al 200326
Slater et al 200610
Zhao et al 200627
Schwinn et al 201019
Lee et al 201028
Fang et al 201018
Newton et al 201011
Cohort Slater et al 201121*,†
Hornik et al 200622*
Scheier and Grenard
201023*
ITS Palmgreen et al
200124‡
Carpenter and
Pechmann 20112‡
4 Meth Project
studies12 14–16‡
CBA 1 Meth Project
study13‡
Miller et al 200020‡
Study quality was appraised with three different tools depending on study design. Redundant or similar items were collapsed. The ‘the intervention was independent of other changes’ item of the ITS checklist was
considered equivalent to the ‘discussion of potential confounder’ item for cohort studies, the ‘formal test for trend’ ITS item was considered equivalent to the ‘statistical accuracy’ item for cohort studies and the
‘completeness of data set’ ITS item was considered equivalent to the ‘attrition’ item for RCT and cohort studies.
*All cohort studies had low risk of bias for the following items: ‘likelihood of outcome already present at enrolment’, ‘clarity of outcome’, ‘reliability of assessment of exposure’, ‘use of other sources to corroborate outcome
measure’, and ‘multiple measure of exposure’.
†Slater 2011 is a mixed RCT-cohort study.
‡All ITS studies and the CBA study had low risk of bias for the following items: ‘intervention unlikely to affect data collection’, and ‘reliable primary outcome measure(s)’.
, high risk of bias; , low risk of bias; , unclear risk of bias; CBA, controlled before and after; Cohort, prospective cohort; ITS, interrupted time-series; RCT, randomised controlled trial; White, not
applicable.
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All cohort studies focused on a clear and appropriate
question. Subgroup comparisons between participants and
dropouts were carried out in only one study.23 The same
study, however, failed to control for potential confounders.
The proportion of participants with no missing data
was reported in only one controlled CBA study.20
Potential confounders were accounted for in only one
ITS study2 and one CBA study.20 A formal test of trend
was not performed in the five Meth Project studies.12–16
One ITS study2 and the two CBA studies13 20 had three
or less data points, which are generally considered insuf-
ficient for drawing reliable conclusions with regard to
intervention effectiveness.
EFFECTS OF MASS-MEDIA CAMPAIGNS
Use of illicit drugs
Experimental studies
Pooled analyses of five RCTs10 11 18 19 28 comprising
n=5470 subjects showed no evidence (p=0.79) of an
effect of mass-media campaigns in modifying use of
illicit drugs (standardised mean difference (SMD)
−0.02; 95% CI −0.15 to 0.12; figure 2 and table 3).
There was some evidence (p=0.020) of heterogeneity
between studies.
The RCT part of a mixed RCT-cohort study (n=3236)
found evidence of effectiveness (p=0.026) for a media-
community intervention (OR 0.60; 95% CI 0.38 to 0.94;
table 3).21
Field studies
Two studies found that the Office of National Drug
Control Policy (ONDCP) National Youth Anti-Drug Media
Campaign (first version) increased use of illicit drugs
among adolescents (table 3). One study (n=3529)
reported a significant increase in past year-use of mari-
juana (OR 1.21; 95% CI 1.19 to 1.65).22 The other study
(n=2515) found some evidence (‘p<0.05’) of an iatrogenic
effect among those aged 15–18 (mean change=0.144),
while there was no evidence (‘p>0.05’) of an effect among
those aged 13–14 (mean change=−0.022).23
The revamped version of the same ONDCP campaign,
Above the Influence, was found effective in a mixed
RCT-cohort study (n=3236), whose cohort part found
strong evidence (p<0.001) of effectiveness (OR 0.26;
95% CI 0.19 to 0.35).21 On a similar note were the find-
ings of an ITS study (n=130 245) which evaluated Above
the Influence and found evidence of reductions in mari-
juana use in the past month (OR 0.67; 95% CI 0.52 to
0.87) among eighth-grade girls.2
The pooled findings of the five Meth Project studies
(n=26 273) suggested no evidence of a change in past-
month use of methamphetamine among subjects aged
12–17 (OR 1.16; 95% CI 0.83 to 1.61), nor among those
aged 18–24 (OR 1.63; 95% CI 0.70 to 3.79) (figure 3A
and table 3). There was, however, evidence (p=0.001) of
a reduction in past-year use of methamphetamine
among those aged 12–17 (OR 0.59; 95% CI 0.43 to
0.81), while there was no evidence of a similar effect
among those aged 18–24 (OR 0.70; 95% CI 0.34 to 1.45;
figure 3B and table 3).
One ITS (n=6371) showed evidence of effectiveness
for past 30-day use of marijuana among high sensation
seekers (p=0.001 for the Fayette sample, p=0.001 for the
first campaign in the Knox sample, p=0.002 for the
second campaign in the Knox sample).24
One CBA study found an increase in use of LSD
(‘p<0.001’; table 3) while no evidence (‘p>0.05’) of dif-
ferences was found for marijuana, cocaine, amphet-
amine and heroin.20
Figure 2 Pooling of randomised controlled trials. Adapted from a previous publication.4
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Table 3 Main findings for use or intention to use illicit drugs
Pooling Outcome Design References Subgroups
Number of
subjects exp
vs ctrl†
Effect
measure
Effect size (95% CI)
or effect direction (p-value)‡
Heterogeneity
p-value¶
Pooled
analyses
Use of illicit drugs RCT Slater et al 2006;10 Fang et al
2010;18 Newton et al 2010;11
Schwinn et al 2010;19 Lee et al
201028
– 2701 vs 2769 SMD, random
effects
−0.02 (−0.15 to 0.12) 0.020*
Intention to use illicit drugs RCT Polansky et al 1999;25 Yzer
et al 2003;26 Zhao et al 2006;27
Fang et al 201018
– 771 vs 499 SMD, fixed effects −0.07 (−0.19 to 0.04) 0.840
Past-month use of
methamphetamine
4 ITS and 1 CBA Meth Project studies12–16 age 12–17 14 865 vs 7497 OR, random effects 1.16 (0.83 to 1.61) –
age 18–24 347 vs 632 OR, random effects 1.63 (0.70 to 3.79) –
Past-year use of
methamphetamine
4 ITS and 1 CBA Meth Project studies12–16 age 12–17 17 105 vs 7497 OR, random effects 0.59 (0.43 to 0.81)** –
age 18–24 1039 vs 632 OR, random effects 0.70 (0.34 to 1.45) –
Single
studies
Lifetime, past 90-day, or
past-30-day use of
marijuana
RCT
(community-media)
Slater et al 201121 – NA (3236) OR, random effects 0.60 (0.38 to 0.94)* –
Cohort
(mass-media)
– OR, random effects 0.26 (0.19 to 0.35)*** –
Past-year use of marijuana Cohort Hornik 200622 – NA (3529) OR, fixed effects 1.21 (1.19 to 1.65)* –
Intention to use marijuana – NA (2915) OR, fixed effects 0.89 (0.79 to 1.00)§ –
Past 12-month episodes of
cannabis intoxication
Cohort Scheier and Grenard et al
201023
age 13–14 NA (2515) mean difference,
SEM
−0.022 –
age 15–18 mean difference,
SEM
0.144* –
Past 30-day use of
marijuana among
high-sensation seekers
ITS Palmgreen et al 200124 Fayette NA (3174) test for slope ↓ (p=0.001) –
Knox, first
campaign
NA (3197) test for slope ↓ (p=0.001)
Knox, second
campaign
test for slope ↓ (p=0.002) –
Past 30-day use of
marijuana (girls, 8th grade)
ITS Carpenter and Pechmann 20112 – NA (130 245) OR, fixed effects 0.67 (0.52 to 0.87)** –
Frequency of use of 10
types of drugs
CBA Miller et al 200020 – 567 vs 431 mean difference,
ANOVA
for LSD: ↑ (p<0.001)
for marijuana, cocaine,
amphetamine, and heroin: ‘no
longer significant’ differences
–
§p<0.10 *p<0.05 **p<0.01 ***p<0.001.
†NA=breakdowns of students exposed to the interventions were not available. Number of analysed subjects is between brackets.
‡Whenever the effect size was not reported, ↓=decreased use or intention to use, and ↑=increased use or intention to use.
¶Heterogeneity test for meta-analyses of RCTs.
ANOVA, analysis of variance; CBA, controlled before and after; Cohort, prospective cohort; ITS, interrupted time-series; RCT, randomised controlled trial; SEM, structural equation modelling; SMD,
standardised mean difference.
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Intention to use drugs
Experimental studies
In one meta-analysis of four randomised controlled
studies involving 1270 participants, there was no evi-
dence of an effect (p=0.21) of media campaigns in
changing intention to use drugs (SMD −0.07; 95% CI
−0.19 to 0.04; figure 2 and table 3).18 25–27 There was no
evidence (p=0.840) of heterogeneity across studies.
Field studies
One study (n=2915) found some evidence (p=0.053) of
a reduction in intentions to use marijuana (OR 0.89;
Figure 3 Pooling of the meth project interrupted time-series studies: predicted and observed probabilities. Adapted from a
previous publication.4
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95% CI 0.79 to 1.00; table 3) for the first version of the
ONDCP’s media campaign.22
DISCUSSION
Mass-media campaigns are commonly used throughout
the world to tackle a broad array of preventable risk
factors or injuries. Such campaigns are seldom evalu-
ated, thus making it difficult to inform policymakers
regarding their effectiveness and sustainability. In this
panorama of overall uncertainty, mass-media campaigns
tackling tobacco and traffic accidents are noteworthy
exceptions as they have been evaluated more frequently
and have shown some evidence for benefit.29 In our
attempt to summarise evidence on the effectiveness of
mass-media campaigns targeting illicit drugs, we
included 19 studies evaluating a number of heteroge-
neous interventions. We grouped interventions accord-
ing to whether they were evaluated with studies
conducted in experimental settings in which participants
were aware of being exposed to media interventions, or
were assessed with studies carried out in a field environ-
ment which are more likely to show the real-life effects
of large national media campaigns, but are also more
prone to risk of bias.
Findings appear to vary considerably according to the
type of intervention and study design. Pooled analyses of
eight interventions evaluated in an experimental setting
provided no evidence of beneficial effects for use or
intention to use illicit drugs, an indicator of possible
future behaviour.30 31 Four interventions evaluated with
eight field studies revealed some evidence of beneficial
effects: (1) the revamped campaign by the Office of
National Drug Control Policy (ONDCP) called Above
the Influence, which was found effective in one study
and effective among eighth-grade girls in another study;
(2) the Be Under Your Own Influence media-
community intervention; (3) the Meth Project
campaign, which was found effective on past-year meth-
amphetamine use, although only among adolescents
aged 12–17 years; and (4) the US televised antimari-
juana campaigns broadcast in Fayette County
(Lexington), Kentucky and in Knox County (Knoxville),
Tennessee, which were found to be effective on high-
sensation seekers. Two mass media campaigns showed
clear iatrogenic effects, most notably, the first version of
the ONDCP’s media campaign My Anti Drug, which was
evaluated by two studies and was found to increase use of
marijuana. An adverse effect was also found for a media-
community intervention evaluated by a CBA study which
provided evidence of increased frequency of LSD use.
No characteristic emerged clearly as a core feature of
successful or unsuccessful campaigns, either regarding
their explicit or implicit theoretical background or their
communication strategies. However, it is worth noting
that two out of the four interventions providing evidence
of effectiveness, the ONDCP’s Above the Influence
national campaign and the Be Under Your Own
Influence media-community intervention promoted
non-use of drugs as a way to support the goals of auton-
omy and achievement of competence, both of which
have been conceptualised as innate psychological needs
that persist over the lifespan.21 Among the interventions
which provided evidence of harmful effects, the first
version of the ONDCP’s media campaign My Anti Drug
was based on a social marketing approach which empha-
sised resistance skills, self-efficacy, normative education
and negative consequences of drug use.32 These media-
tors are suspected to have increased the perception of
prevalence of drug use in the target population.33
An important reason for the weak evidence obtained
by this review is the large variation in mass-media inter-
vention type and study design. Similar interventions
were often evaluated with different study designs while
different interventions were sometimes evaluated with
the same study design. Pooled analyses could thus be
undertaken only for a few similar interventions evalu-
ated with the same study design, and such small sets of
pooled studies did not allow sensitivity analyses to be
carried out. We did not set any time or language con-
straints to our search, accepted all types of controlled
study designs and obtained unpublished data by estab-
lishing direct contact with the authors of the original
papers. Unfortunately, owing to the paucity and incon-
sistency of available evidence, we cannot draw general
conclusions as to whether media campaigns are effective
in preventing the use or the intention to use illicit
drugs. This observation is in line with the findings of
similar reviews that used more restrictive inclusion
criteria.29 34
The evidence base accrued so far on media cam-
paigns targeting illicit drugs allows us to make at least
two remarks. First, such campaigns can be evaluated—a
fact that is often questioned in several parts of the
world—and properly conducted evaluation studies can
provide benefits to both research and practice. Second,
in the worst-case scenario, media campaigns can be
both ineffective and harmful. Contrary to common
belief, antidrug media campaigns may be damaging
and their dissemination is ethically unacceptable
without a prior assessment of their effects.35 36 New
campaigns should be implemented in the framework of
rigorous evaluation studies, ideally in field settings with
cohort or ITS study designs. A better understanding of
which media interventions work best is likely to result
in a more effective prevention of drug use and
increased efficiency in the management of public
resources.
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